clinical trial · NCT07047508
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
Boehringer Ingelheim·—·not yet recruiting·n = 3,000
Heart FailurePreserved Ejection Fraction
brief summary
The main objective of the study is to describe the effectiveness and safety outcomes among Chinese hospitalized heart failure with preserved ejection fraction (HFpEF) patients initiating Jardiance® in the real-world setting.
started
Jan 31, 2028
primary completion
Dec 31, 2028
completion
Dec 31, 2028
last updated
Feb 13, 2026
official title
A Non-interventional Study of the Effectiveness and Safety Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) Initiating Jardiance in China: A Sub-study of the Post-marketing Study of Jardiance Among Patients With Heart Failure in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol